Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,005 CAD | -.--% |
|
-.--% | -.--% |
Attività
Vendite per attività
CAD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Diagnosis and Treatment of Neurological Diseases and Disorders
100,0
%
| 4 | 100,0 % | 0 | 100,0 % | -99,07% |
Vendite per regione
CAD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 4 | 100,0 % | 0 | 100,0 % | -99,07% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Deborah Rathjen
CEO | Chief Executive Officer | - | 21/09/17 |
Dave Jenkins
DFI | Director of Finance/CFO | - | 01/07/21 |
Mei Mei Tian
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/12 |
Graeme Dick
IRC | Investor Relations Contact | - | 01/11/11 |
Christopher Lowe
SEC | Corporate Secretary | 56 | 03/10/17 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
John Hemeon
BRD | Director/Board Member | 59 | - |
David Wurzer
BRD | Director/Board Member | 65 | 27/07/18 |
Deborah Rathjen
CEO | Chief Executive Officer | - | 21/09/17 |
Director/Board Member | 63 | 01/06/18 | |
John E. Curran
BRD | Director/Board Member | - | 27/07/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 79 414 015 | 77 784 778 ( 97,95 %) | 0 | 97,95 % |
Coordinate società
![Indirizzo Bioasis Technologies Inc.(BTI)](https://cdn.zonebourse.com/static/address/49478113.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
-.--% | 291.738 | |
+21,89% | 45,01 Mrd | |
+47,36% | 40,96 Mrd | |
-5,28% | 38,62 Mrd | |
+34,74% | 32,6 Mrd | |
-8,34% | 27,49 Mrd | |
+19,13% | 27,17 Mrd | |
+48,48% | 14,61 Mrd | |
+42,62% | 12,95 Mrd | |
-2,87% | 11,36 Mrd |
- Borsa valori
- Azioni
- Azione BTI
- Società Bioasis Technologies Inc.